Maria Breun, Tim Schulz, Camelia M Monoranu, Ralf-Ingo Ernestus, Cordula Matthies, Tabea Hartung, Lan Kluwe, Said Farschtschi
{"title":"9例散发性前庭神经鞘瘤中两种致病性NF2变异的相似等位基因频率","authors":"Maria Breun, Tim Schulz, Camelia M Monoranu, Ralf-Ingo Ernestus, Cordula Matthies, Tabea Hartung, Lan Kluwe, Said Farschtschi","doi":"10.21873/cgp.20516","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>Vestibular schwannomas are benign tumors on the vestibular nerve caused by bi-allelic inactivation of the <i>NF2</i> tumor suppressor gene. This study identifies sporadic vestibular schwannomas with two pathogenic <i>NF2</i>-variants in each of them and compares the allele-frequencies of the two variants.</p><p><strong>Patients and methods: </strong>Sporadic vestibular schwannomas were subjected to genetic analysis regarding pathogenic variants in the <i>NF2</i> gene using targeted sequencing. Cases with two different pathogenic <i>NF2</i> variants were identified and the allele-frequencies of the two variants in each tumor were compared.</p><p><strong>Results: </strong>Nine tumors were identified which had two different pathogenic <i>NF2</i> variants in each of them. For all the 9 tumors, the allele-frequencies of the two pathogenic <i>NF2</i> variants in each were nearly identical.</p><p><strong>Conclusion: </strong>This finding may indicate that the two inactivating <i>NF2</i> variants occurred shortly after one another, leaving no room for the Schwann cells with one inactivating <i>NF2</i> variant to expand. Alternatively, the variants occurred in a late development stage whereas Schwann cells do not expand anymore or expand only extremely slowly. In addition, our finding suggests that Schwann cells with one inactivating variant do not gain a growth advantage.</p>","PeriodicalId":9516,"journal":{"name":"Cancer Genomics & Proteomics","volume":"22 3","pages":"491-495"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041872/pdf/","citationCount":"0","resultStr":"{\"title\":\"Similar Allele Frequencies of Two Pathogenic <i>NF2</i> variants in Each of Nine Sporadic Vestibular Schwannomas.\",\"authors\":\"Maria Breun, Tim Schulz, Camelia M Monoranu, Ralf-Ingo Ernestus, Cordula Matthies, Tabea Hartung, Lan Kluwe, Said Farschtschi\",\"doi\":\"10.21873/cgp.20516\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>Vestibular schwannomas are benign tumors on the vestibular nerve caused by bi-allelic inactivation of the <i>NF2</i> tumor suppressor gene. This study identifies sporadic vestibular schwannomas with two pathogenic <i>NF2</i>-variants in each of them and compares the allele-frequencies of the two variants.</p><p><strong>Patients and methods: </strong>Sporadic vestibular schwannomas were subjected to genetic analysis regarding pathogenic variants in the <i>NF2</i> gene using targeted sequencing. Cases with two different pathogenic <i>NF2</i> variants were identified and the allele-frequencies of the two variants in each tumor were compared.</p><p><strong>Results: </strong>Nine tumors were identified which had two different pathogenic <i>NF2</i> variants in each of them. For all the 9 tumors, the allele-frequencies of the two pathogenic <i>NF2</i> variants in each were nearly identical.</p><p><strong>Conclusion: </strong>This finding may indicate that the two inactivating <i>NF2</i> variants occurred shortly after one another, leaving no room for the Schwann cells with one inactivating <i>NF2</i> variant to expand. Alternatively, the variants occurred in a late development stage whereas Schwann cells do not expand anymore or expand only extremely slowly. In addition, our finding suggests that Schwann cells with one inactivating variant do not gain a growth advantage.</p>\",\"PeriodicalId\":9516,\"journal\":{\"name\":\"Cancer Genomics & Proteomics\",\"volume\":\"22 3\",\"pages\":\"491-495\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12041872/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Genomics & Proteomics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/cgp.20516\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Genomics & Proteomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/cgp.20516","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Similar Allele Frequencies of Two Pathogenic NF2 variants in Each of Nine Sporadic Vestibular Schwannomas.
Background/aim: Vestibular schwannomas are benign tumors on the vestibular nerve caused by bi-allelic inactivation of the NF2 tumor suppressor gene. This study identifies sporadic vestibular schwannomas with two pathogenic NF2-variants in each of them and compares the allele-frequencies of the two variants.
Patients and methods: Sporadic vestibular schwannomas were subjected to genetic analysis regarding pathogenic variants in the NF2 gene using targeted sequencing. Cases with two different pathogenic NF2 variants were identified and the allele-frequencies of the two variants in each tumor were compared.
Results: Nine tumors were identified which had two different pathogenic NF2 variants in each of them. For all the 9 tumors, the allele-frequencies of the two pathogenic NF2 variants in each were nearly identical.
Conclusion: This finding may indicate that the two inactivating NF2 variants occurred shortly after one another, leaving no room for the Schwann cells with one inactivating NF2 variant to expand. Alternatively, the variants occurred in a late development stage whereas Schwann cells do not expand anymore or expand only extremely slowly. In addition, our finding suggests that Schwann cells with one inactivating variant do not gain a growth advantage.
期刊介绍:
Cancer Genomics & Proteomics (CGP) is an international peer-reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research. In this site you may find information concerning the editorial board, editorial policy, issue contents, subscriptions, submission of manuscripts and advertising. The first issue of CGP circulated in January 2004.
Cancer Genomics & Proteomics is a journal of the International Institute of Anticancer Research. From January 2013 CGP is converted to an online-only open access journal.
Cancer Genomics & Proteomics supports (a) the aims and the research projects of the INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH and (b) the organization of the INTERNATIONAL CONFERENCES OF ANTICANCER RESEARCH.